Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by Liked2Thinkon Apr 04, 2021 1:02am
164 Views
Post# 32934675

RE:RE:Multiple tests, FDA path and I think you know which partner.

RE:RE:Multiple tests, FDA path and I think you know which partner.Whats a possible explanation for the plan now.

1. Someone has cancer already
2. Care oncology starts their program of treatment
3. Aristotle test is used every 12 weeks to determine how well the Care Oncology program is doing or if they have to change something?

I mean it sounds good but I dont understand part one.  why would we want to wait until someone already knows they have cancer.  They could have had it for a year before they found out they had it.

The way I thought it was going to be possible was anyone could request an Aristotle test from one of our "large health care partners" or even run it like the covid test.  If you wanted one anyone could get one.

Frankly I think I would have a test done every couple years out of my own pocket just in case.  

I would add a 
0.5 step before #1 and make it that anyone could get Aristotle if they wanted to.  If they have cancer they move into the AVRT program, if they dont then they are good for a couple years or whatever.

Will these tests be covered under health insurance?  not too many people could afford a bunch of 1500 dollar tests in a 2 year period. 
<< Previous
Bullboard Posts
Next >>